عوز الأورنيثين ناقل الكربامويل (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "عوز الأورنيثين ناقل الكربامويل" in Arabic language version.

refsWebsite

Global rank Arabic rank

10nih.gov

4^th place

6^th place

5doi.org

2^nd place

5^th place

4web.archive.org

1^st place

1omim.org

4,380^th place

2,257^th place

1clinicaltrials.gov

5,225^th place

3,308^th place

1archive.org

6^th place

3^rd place

1worldcat.org

5^th place

4^th place

archive.org

Maestri، N. E.؛ Clissold، D.؛ Brusilow، S. W. (1 مارس 1999). "Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis". The Journal of Pediatrics. ج. 134 ع. 3: 268–272. DOI:10.1016/s0022-3476(99)70448-8. ISSN:0022-3476. PMID:10064660.

clinicaltrials.gov

"Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset OTC Deficiency - Full Text View - ClinicalTrials.gov". clinicaltrials.gov (بالإنجليزية). Archived from the original on 2021-04-05. Retrieved 2020-08-07.

doi.org

Wraith، J. E. (2001). "Ornithine carbamoyltransferase deficiency". Archives of Disease in Childhood. ج. 84 ع. 1: 84–88. DOI:10.1136/adc.84.1.84. PMC:1718609. PMID:11124797.
Walker، V. (2009). "Ammonia toxicity and its prevention in inherited defects of the urea cycle". Diabetes, Obesity and Metabolism. ج. 11 ع. 9: 823–835. DOI:10.1111/j.1463-1326.2009.01054.x. PMID:19531057.
Deakin، C. T.؛ Alexander، I. E.؛ Kerridge، I. (2009). "Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?". Molecular Therapy. ج. 17 ع. 11: 1842–1848. DOI:10.1038/mt.2009.223. PMC:2835028. PMID:19773741.
Morioka، D.؛ Kasahara، M.؛ Takada، Y.؛ Shirouzu، Y.؛ Taira، K.؛ Sakamoto، S.؛ Uryuhara، K.؛ Egawa، H.؛ Shimada، H.؛ Tanaka، K. (2005). "Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University". Liver Transplantation. ج. 11 ع. 11: 1332–1342. DOI:10.1002/lt.20587. PMID:16237708.
Maestri، N. E.؛ Clissold، D.؛ Brusilow، S. W. (1 مارس 1999). "Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis". The Journal of Pediatrics. ج. 134 ع. 3: 268–272. DOI:10.1016/s0022-3476(99)70448-8. ISSN:0022-3476. PMID:10064660.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wraith، J. E. (2001). "Ornithine carbamoyltransferase deficiency". Archives of Disease in Childhood. ج. 84 ع. 1: 84–88. DOI:10.1136/adc.84.1.84. PMC:1718609. PMID:11124797.
Walker، V. (2009). "Ammonia toxicity and its prevention in inherited defects of the urea cycle". Diabetes, Obesity and Metabolism. ج. 11 ع. 9: 823–835. DOI:10.1111/j.1463-1326.2009.01054.x. PMID:19531057.
Lichter-Konecki، U.؛ Caldovic، L.؛ Morizono، H.؛ Simpson، K.؛ Pagon، R. A.؛ Adam، M. P.؛ Bird، T. D.؛ Dolan، C. R.؛ Fong، C. T.؛ Stephens، K. (1993). "Ornithine Transcarbamylase Deficiency". GeneReviews®. PMID:24006547.
Deakin، C. T.؛ Alexander، I. E.؛ Kerridge، I. (2009). "Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?". Molecular Therapy. ج. 17 ع. 11: 1842–1848. DOI:10.1038/mt.2009.223. PMC:2835028. PMID:19773741.
Morioka، D.؛ Kasahara، M.؛ Takada، Y.؛ Shirouzu، Y.؛ Taira، K.؛ Sakamoto، S.؛ Uryuhara، K.؛ Egawa، H.؛ Shimada، H.؛ Tanaka، K. (2005). "Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University". Liver Transplantation. ج. 11 ع. 11: 1332–1342. DOI:10.1002/lt.20587. PMID:16237708.
Maestri، N. E.؛ Clissold، D.؛ Brusilow، S. W. (1 مارس 1999). "Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis". The Journal of Pediatrics. ج. 134 ع. 3: 268–272. DOI:10.1016/s0022-3476(99)70448-8. ISSN:0022-3476. PMID:10064660.

ncbi.nlm.nih.gov

Wraith، J. E. (2001). "Ornithine carbamoyltransferase deficiency". Archives of Disease in Childhood. ج. 84 ع. 1: 84–88. DOI:10.1136/adc.84.1.84. PMC:1718609. PMID:11124797.
"Human ornithine transcarbamylase (OTC) mRNA, complete coding sequence". US National Library of Medicine. مؤرشف من الأصل في 2020-11-11.
Deakin، C. T.؛ Alexander، I. E.؛ Kerridge، I. (2009). "Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?". Molecular Therapy. ج. 17 ع. 11: 1842–1848. DOI:10.1038/mt.2009.223. PMC:2835028. PMID:19773741.

ghr.nlm.nih.gov

"Ornithing transcarbamylase deficiency". United States National Library of Medicine. 22 مايو 2018. مؤرشف من الأصل في 2020-09-26. اطلع عليه بتاريخ 2018-05-25.

omim.org

"#311250 - Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To". Johns Hopkins University. مؤرشف من الأصل في 2021-03-27. اطلع عليه بتاريخ 2014-01-01.

web.archive.org

"Ornithing transcarbamylase deficiency". United States National Library of Medicine. 22 مايو 2018. مؤرشف من الأصل في 2020-09-26. اطلع عليه بتاريخ 2018-05-25.
"#311250 - Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To". Johns Hopkins University. مؤرشف من الأصل في 2021-03-27. اطلع عليه بتاريخ 2014-01-01.
"Human ornithine transcarbamylase (OTC) mRNA, complete coding sequence". US National Library of Medicine. مؤرشف من الأصل في 2020-11-11.
"Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset OTC Deficiency - Full Text View - ClinicalTrials.gov". clinicaltrials.gov (بالإنجليزية). Archived from the original on 2021-04-05. Retrieved 2020-08-07.

worldcat.org

Maestri، N. E.؛ Clissold، D.؛ Brusilow، S. W. (1 مارس 1999). "Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis". The Journal of Pediatrics. ج. 134 ع. 3: 268–272. DOI:10.1016/s0022-3476(99)70448-8. ISSN:0022-3476. PMID:10064660.